Fidelity International’s Organon & Co OGN Stock Holding History

Fidelity International’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,161	Closed	-$168K	–	838
2023 Q1	$168K	Sell	7,161 -551	-7%	-$14.8K	﹤0.01%	761
2022 Q4	$215K	Buy	7,712 +629	+9%	+$16.1K	﹤0.01%	766
2022 Q3	$166K	Buy	+7,083	New	+$214K	﹤0.01%	781
2021 Q3	–	Sell	-7,318	Closed	-$221K	–	873
2021 Q2	$221K	Buy	+7,318	New	+$241K	﹤0.01%	813

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Fidelity International's OGN Position: Q2 2023 in Review

Fidelity International sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 7,161 shares — an estimated $168K sold.

Fidelity International first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $221K in Q2 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Fidelity International reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Fidelity International sold 7,161 Organon & Co shares in Q2 2023, an estimated $168K.
Fidelity International first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
Fidelity International's Organon & Co position peaked at $221K in Q2 2021.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Fidelity International's 13F filing for Q2 2023, filed 11 Aug 2023.